These myeloid cells are attracted from the circulation to the tumor site via chemokine pathways that tumor cells co-opt to enhance myeloid cell attraction like CCL2 (Schmid and Varner, 2010; Gu et al., 2021). Here, CCL2 is linked to neoplasm.